34 Results for "

F9

" in MedChemExpress (MCE) Product Catalog:
Products (34)

34 Results for "F9" in MCE Product Catalog:

19
19 Publications Verification
Cat. No.: HY-P99145

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2) is an anti-mouse PD-L1/B7-H1 IgG2b antibody inhibitor derived from host rat. Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2) blocks PD-1 signaling. Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2) can be used for the research of cancer, such as colon cancer .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P99029
CAS No.: 2169232-81-7
Synonyms: Hu5F9-G4

Target:  

CD47

Research Areas:  

Cancer

Magrolimab (Hu5F9-G4) is a humanized anti-CD47 antibody. Magrolimab, an IgG4 isotype, lacks ADCC function and exhibits relatively weak ADCP effector function. Magrolimab can be used for the study of malignant bone tumors and breast cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70231
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuCoagulation factor IX/F9, His; F9; Coagulation factor IX; Christmas factor; Plasma thromboplastin component; Coagulation factor IXa light chain; Coagulation factor IXa heavy chain
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P72544
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Interleukin-36 gamma; IL-36γ; IL36G; IL-1F9; IL-1H1
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-14649G
CAS No.: 302-79-4
Synonyms: Vitamin A acid (GMP); all-trans-Retinoic acid (GMP); ATRA (GMP)
Retinoic acid (Vitamin A acid) (GMP) is Retinoic acid (HY-14649) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Retinoic acid is an agonist of RAR nuclear receptors .
loading...
    loading...
Cat. No.: HY-P99232
CAS No.: 1497400-26-6
Synonyms: 5F9 Monoclonal antibody; TAK-164 Antibody
Indusatumab (5F9 Monoclonal antibody) is a monoclonal antibody against human GUCY2C (Guanylate cyclase 2C). Indusatumab fails to bind to granulocytes or erythrocytes. Indusatumab can be used to synthesize ADCs, such as Indusatumab vedotin (HY-P99662). Indusatumab can be used in cancer research .
loading...
    loading...
Cat. No.: HY-P99145A

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2-Mouse IgG1) is a recombinant chimeric version of the original 10F.9G2 antibody (HY-P99145). The variable domain sequences are identical to the original 10F.9G2 but the constant region sequences have been switched from rat IgG2b to mouse IgG1. Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2-Mouse IgG1) contains no Fc mutations just as the original rat IgG2b antibody does not. Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2-Mouse IgG1) blocks PD-1 signaling. Anti-Mouse PD-L1/B7-H1 Antibody (10F.9G2-Mouse IgG1) can be used for the research of cancer.
loading...
    loading...
Cat. No.: HY-P990171

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Anti-Mouse PD-L1/B7-H1 (LALA-PG) Antibody (10F.9G2) is a recombinant chimeric version of the original 10F.9G2 antibody (HY-P99145). The variable domain sequences are identical to the original 10F.9G2 but the constant region sequences have been switched from rat IgG2b to mouse IgG2a. Anti-Mouse PD-L1/B7-H1 (LALA-PG) Antibody (10F.9G2) contains a LALA-PG mutation in the Fc fragment rendering it unable to bind to endogenous Fcγ receptors. Anti-Mouse PD-L1/B7-H1 (LALA-PG) Antibody (10F.9G2) blocks PD-1 signaling. Anti-Mouse PD-L1/B7-H1 (LALA-PG) Antibody (10F.9G2) can be used for the research of cancer.
loading...
    loading...
Cat. No.: HY-P990172

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Anti-Mouse PD-L1/B7-H1 (D265A) Antibody (10F.9G2) is a recombinant chimeric version of the original 10F.9G2 antibody (HY-P99145). The variable domain sequences are identical to the original 10F.9G2 but the constant region sequences have been switched from rat IgG2b to mouse IgG1. Anti-Mouse PD-L1/B7-H1 (D265A) Antibody (10F.9G2) contains a D265A mutation in the Fc fragment rendering it unable to bind to endogenous Fcγ receptors. Anti-Mouse PD-L1/B7-H1 (D265A) Antibody (10F.9G2) blocks PD-1 signaling. Anti-Mouse PD-L1/B7-H1 (D265A) Antibody (10F.9G2) can be used for the research of cancer.
loading...
    loading...
Cat. No.: HY-RS04648
Research Areas:  

Others

F9 Human Pre-designed siRNA Set A contains three designed siRNAs for F9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS24189
Research Areas:  

Others

F9 Rat Pre-designed siRNA Set A contains three designed siRNAs for F9 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS17724
Research Areas:  

Others

F9 Mouse Pre-designed siRNA Set A contains three designed siRNAs for F9 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-162131
Research Areas:  

Cancer

Antitumor agent-132 (Compound F9) is an antitumor agent. Antitumor agent-132 induces cell apoptosis and increases intracellular reactive oxygen species and reduces MMP .
loading...
    loading...
Cat. No.: HY-158320
Target:  

Bacterial

Research Areas:  

Infection

T3SS-IN-5 (Compound F9) is a specific inhibitor of the type III secretion system (T3SS). T3SS-IN-5 reduces bacterial pathogenicity without affecting bacterial viability by inhibiting the expression of genes associated with T3SS .
loading...
    loading...
Cat. No.: HY-P9940A

Target:  

Factor VIII

Research Areas:  

Cardiovascular Disease

Emicizumab (Anti-F9 & Factor IX) is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab (Anti-F9 & Factor IX) can be used for hemophilia A research .
loading...
    loading...
Cat. No.: HY-13589
CAS No.: 159776-69-9
Synonyms: LU103793 free base
Research Areas:  

Cancer

Cemadotin (LU103793) is a water-soluble synthetic analogue of Dolastatin 15 (HY-P1126) that inhibits cell proliferation in vitro and the growth of tumor xenografts in mice. Cemadotin blocks cells at mitosis, and exhibits Ki value of 1 μM for inhibiting tubulin. Cemadotin can be used to research anticancer .
loading...
    loading...
Cat. No.: HY-13631N
CAS No.: 2489613-17-2
Synonyms: (9R)-DX8951f
Research Areas:  

Cancer

(9R)-Exatecan (DX8951f) is the (1R,9S) stereoisomer of Exatecan (HY-13631). Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research.
loading...
    loading...
Cat. No.: HY-P74240
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Coagulation Factor IX; F9; FIX; HEMB; PTC
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P810760
Synonyms: Coagulation factor IX, Christmas factor, Plasma thromboplastin component, PTC, F9

Host:  

Rabbit

Application:  

WB, ICC/IF

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-155741
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

CB2 PET Radioligand 1 (compound [18F]9) is a PET Radioligand targeting to hCB2 (Ki=7.7 nM). CB2 PET Radioligand 1 is prepared with Cu-mediated 18F-fluorination. CB2 PET Radioligand 1 shows high brain uptake in a murine model of neuroinflammation .
loading...
    loading...